CN102863434A - Synthetic method of nifuratel - Google Patents

Synthetic method of nifuratel Download PDF

Info

Publication number
CN102863434A
CN102863434A CN2012104010592A CN201210401059A CN102863434A CN 102863434 A CN102863434 A CN 102863434A CN 2012104010592 A CN2012104010592 A CN 2012104010592A CN 201210401059 A CN201210401059 A CN 201210401059A CN 102863434 A CN102863434 A CN 102863434A
Authority
CN
China
Prior art keywords
nifuratel
synthetic method
reaction
methylthiomethyl
under
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012104010592A
Other languages
Chinese (zh)
Other versions
CN102863434B (en
Inventor
刘新泉
王平
刘明霞
李晓峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Luoxin Pharmaceutical Group Co Ltd
Original Assignee
Shandong Luoxin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Luoxin Pharmaceutical Co Ltd filed Critical Shandong Luoxin Pharmaceutical Co Ltd
Priority to CN201210401059.2A priority Critical patent/CN102863434B/en
Publication of CN102863434A publication Critical patent/CN102863434A/en
Application granted granted Critical
Publication of CN102863434B publication Critical patent/CN102863434B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention belongs to the field of medicine synthesis, and discloses a synthetic method of nifuratel. The synthetic method of nifuratel is to carry out ring closing reaction under the alkaline condition of sodium methoxide, therefore, the metallic sodium can be avoided being used, and the safety in production can be ensured; meanwhile, the reaction is easy to generate, the process is easy to control, high yield of the synthesized nifuratel is achieved, few impurities are generated, and the quality is stable; and moreover, the synthetic method of nifuratel is simple in operation, and the raw material is easy to obtain; the used solvent and the raw material out of the reaction can be recycled along with low cost; no waste liquid is generated in each step of the reaction; the pollution is greatly reduced; and the synthetic method is suitable for industrial production.

Description

A kind of synthetic method of nifuratel
Technical field
The invention belongs to the synthetic field of medicine, relate in particular to a kind of synthetic method of nifuratel.
Background technology
Nifuratel (Cefditoren Pivoxil) chemistry is by name: the 5-[(methylthio group) methyl]-3-[[(5-nitro-2-furans) methylene radical] amino]-the 2-oxazolidone, molecular formula is C10H11N3O5S, and molecular weight is 285.28, and chemical structural formula is as follows:
Nifuratel is that Italian Poli Industria Chimica S.p.A company develops listing the sixties, itrofurans Antibiotics medicine, effect with the polyinfection of significant treatment vagina, it is active equivalent with metronidazole that it kills trichomonad, have simultaneously anti-microbial effect, can also effectively kill chlamydia trachomatis and mycoplasma, candidiasis is also had certain activity.Oral and the vagina administration of nifuratel shows that its tolerance is good, and is equivalent to curative ratio and penbritin, the Pyocianil of bacterial vaginitis also without the resistance phenomenon, and adverse reaction rate significantly is lower than penbritin, Pyocianil.Nifuratel is a broad-spectrum antibiotics, especially the common disease substance of gynecological infection such as Gram-positive and negative bacteria, trichomonad, mould, chlamydozoan and mycoplasma there is strong killing action, to by bacterium, trichomonad, the microbial vulva of mould and beads, vaginal infection and leucorrhea increasing and urinary system infection, digestive tube loeschiasis and giardiasis have good therapeutic action.
At present according to bibliographical information, nifuratel synthetic mainly contains following two kinds of methods:
Method one: referring to belgian patent Belg pat.635608 (1963); CA61:16069c, its chemical equation is as follows:
Figure BDA00002280352100021
Method two: referring to French Patent Fr.M 4544(1966); CA 66:59221a, its chemical equation is as follows:
Figure BDA00002280352100022
Above-mentioned two kinds of methods there is no the difference of essence, all are take epoxy chloropropane as starting raw material, only are that response hierarchy is slightly different when preparation 3-methylthio group-2-hydroxyl-propyl hydrazine.But above-mentioned synthetic method all is to carry out in the alkaline environment of methyl alcohol-sodium methylate, and in the production of industrially scalable, owing to having used sodium Metal 99.5, can bring the danger of blast.Above-mentioned synthetic method reactivity and yield are all lower in addition, and product impurity is many, purity is low.
Summary of the invention
In view of this, the object of the invention is to for problems of the prior art, provide that a kind of yield is high, impurity is few, the synthetic method of stay-in-grade nifuratel.
For realizing purpose of the present invention, the present invention adopts following technical scheme:
A kind of synthetic method of nifuratel may further comprise the steps:
Step 1, epoxy chloropropane is added in the reaction flask, at 0~10 ℃ of lower sodium methyl mercaptide that slowly drips, drip finish after, reaction is 3 hours under the room temperature, underpressure distillation is collected cut and is got the 2-(methylthiomethyl)-oxirane; The mol ratio of wherein said epoxy chloropropane and sodium methyl mercaptide is 1:5;
Step 2, hydrazine hydrate is added in the there-necked flask, under 90~95 ℃, splashes into the 2-(methylthiomethyl)-oxirane, dripped the Bi Jixu insulation reaction 2 hours, underpressure distillation is collected cut and is got 3-methylthio group-2-hydroxyl-propyl hydrazine; Wherein said hydrazine hydrate and 2-(methylthiomethyl)-mol ratio of oxirane is 1:1 ~ 1.1:1;
Step 3, get 3-methylthio group-2-hydroxyl-propyl hydrazine and add methylcarbonate, reacting by heating gets N-amino-5-methylthiomethyl-2-oxazolidone under the alkali existence condition; The mol ratio of wherein said 3-methylthio group-2-hydroxyl-propyl hydrazine and methylcarbonate is 1: 1 ~ 1:1.2;
Step 4, get the 5-Nitrofulral diacetate and add ethanol and under the diluted acid existence condition, be hydrolyzed to get the 5-nitryl furfural; The mol ratio of wherein said ethanol and 5-Nitrofulral diacetate is 1:0.05;
Step 5, under the lucifuge condition, N-amino-5-methylthiomethyl-2-oxazolidone is mixed with the 5-nitryl furfural, 15-30 ℃ stir 2 hours after, left standstill 2 hours, filter, the filter cake washing with alcohol drying, get the nifuratel crude product, recrystallization purifying gets the nifuratel sterling; The mol ratio of wherein said N-amino-5-methylthiomethyl-2-oxazolidone and 5-nitryl furfural is 1:1 ~ 1: 1.05.
Preparation method of the present invention is take epoxy chloropropane as reaction raw materials, generate the 2-(methylthiomethyl with sodium methyl mercaptide generation substitution reaction)-oxirane, the 2-(methylthiomethyl)-and oxirane and hydrazine hydrate generation hydrazinolysis reaction 3-methylthio group-2-hydroxyl-propyl hydrazine, then carry out ring-closure reaction under 3-methylthio group-2-hydroxyl-propyl hydrazine and the methylcarbonate alkali existence condition and obtain N-amino-5-methylthiomethyl-2-oxazolidone.The 5-nitryl furfural condensation that N-amino-5-methylthiomethyl-2-oxazolidone and the hydrolysis of 5-Nitrofulral diacetate obtain generates the nifuratel crude product, and last recrystallization purifying obtains nifuratel.Synthetic method of the present invention is carried out ring-closure reaction under the alkaline condition of sodium methylate, avoided the use of sodium Metal 99.5, guarantees production safety.Improved simultaneously the yield of nifuratel, the product foreign matter content that has reduced has improved the purity of nifuratel sterling.
As preferably, the described collection cut of step 1 is for collecting 42-60 ℃ of cut.
As preferably, the described underpressure distillation of step 2 is for being concentrated into first thickness, again-0.095 ~-distill under the 0.1MPa vacuum tightness.
As preferably, the described diluted acid of step 3 is dilute sulphuric acid.
As preferably, the reaction conditions of the described hydrolysis of step 4 is heating reflux reaction 30 minutes.
As preferably, the described recrystallization purifying of step 5 is specially under the lucifuge condition, gets the nifuratel crude product, press g/mL, add the Glacial acetic acid of 10 times of volumes of nifuratel crude product, be heated to and boil, charcoal absorption, filtered while hot, filtrate is left standstill crystallization, filter after being cooled to room temperature, filter cake with washing with alcohol to the product redfree, water, washing with alcohol are drying to obtain after draining again.
Can find out from above-mentioned technical scheme, the invention provides a kind of synthetic method of nifuratel.The synthetic method of nifuratel of the present invention is carried out ring-closure reaction under the alkaline condition of sodium methylate, avoided the use of sodium Metal 99.5, guarantees production safety.Propose simultaneously reaction and easily occur, the nifuratel yield that process is easily controlled, synthesized is high, impurity is few, steady quality.And the synthetic method of nifuratel of the present invention is simple to operate, and raw material is easy to get, used solvent and to participate in the equal recoverable cost of raw material of reaction low, and each step reaction does not have waste liquid substantially, greatly reduces pollution, is more suitable for suitability for industrialized production.
Embodiment
The embodiment of the invention discloses a kind of synthetic method of nifuratel.Those skilled in the art can use for reference this paper content, suitably improve processing parameter and realize.Special needs to be pointed out is, all similarly replace and change apparent to those skilled in the art, and they all are deemed to be included in the present invention.Method of the present invention is described by preferred embodiment, and the related personnel obviously can change or suitably change and combination method as herein described within not breaking away from content of the present invention, spirit and scope, realizes and use the technology of the present invention.
In order further to understand the present invention, the present invention is described in detail below in conjunction with embodiment.Embodiment 1: the optimization of process conditions of the synthetic method step 1 of nifuratel
In the building-up process of nifuratel, the present invention investigates the temperature of the described substitution reaction of synthetic method step 1 of nifuratel to reaction solution color and 2-(methylthiomethyl)-impact of oxirane yield, the results are shown in Table 1.
The processing condition of table 1 step 1
Temperature of reaction Reaction solution color yield (%)
7~22℃ Yellow 23.7
0~10℃ Colourless 52.5
50~75℃ Yellow 11.0
15~25℃ Yellow 32.6
-3~5℃ Colourless 58.6
0~5℃ Colourless 58.0
By table 1 result as seen, in the building-up process of nifuratel, the described substitution reaction temperature of step 1 is higher, and the yellow impurities of generation is more, intermediate 2-(methylthiomethyl)-the oxirane yield is lower.Therefore temperature of reaction is defined as 0~10 ℃.Further detect the reactant of the rear raffinate of distillation and sodium methyl mercaptide, do not obtain the 2-(methylthiomethyl)-oxirane, illustrate to drip sodium methyl mercaptide solution, continue reaction 3 hours, epoxy chloropropane reacts completely in reaction solution.Consider the influence factor of each side, the processing condition of the synthetic method step 1 of nifuratel are preferably: the control temperature is 0~10 ℃; Drip sodium methyl mercaptide solution, continue reaction 3 hours; Underpressure distillation is collected 42-60 ℃ of cut and is got intermediate 2-(methylthiomethyl)-oxirane.
Embodiment 2: the optimization of process conditions of the synthetic method step 2 of nifuratel
In the building-up process of nifuratel, the post-treating method of the intermediate 3-methylthio group that the present invention further prepares-2-hydroxyl-propyl hydrazine is studied, and the results are shown in Table 2.
The processing condition of the aftertreatment of table 2 3-methylthio group-2-hydroxyl-propyl hydrazine
Figure BDA00002280352100061
By table 2 result as seen, in the building-up process of nifuratel, if reaction solution without molecular distillation, final nifuratel quality product can be subject to more impact.Therefore determine reaction solution first under lower temperature and vacuum tightness, boil off hydrazine hydrate and water after, under condition of high vacuum degree, distill out again the high 3-methylthio group of purity-2-hydroxyl-propyl hydrazine.
Embodiment 4: the optimization of process conditions of the synthetic method step 3 of nifuratel
In the building-up process of nifuratel, the present invention has investigated different hydrolysising solvents on the preparation of intermediate 5-nitryl furfural and on the impact of end product, the results are shown in Table 3.
Table 3 different solvents is on the impact of the preparation of intermediate 5-nitryl furfural
Hydrolysising solvent The result
Dilute hydrochloric acid Be difficult to obtain 5-nitryl furfural solution, the nifuratel of trial-production off quality
Dilute sulphuric acid The 5-nitryl furfural solution that is easy to get, the nifuratel of trial-production up-to-standard
By table 3 result as seen, compare with dilute hydrochloric acid, the 5-Nitrofulral diacetate refluxes, is hydrolyzed 30 minutes and is easy to obtain 5-nitryl furfural solution in dilute sulphuric acid, and final nifuratel quality product is also qualified, therefore determines the technique that adopts the 5-Nitrofulral diacetate to be hydrolyzed in dilute sulphuric acid.
Embodiment 5: nifuratel synthetic
1,2-(methylthiomethyl)-preparation of oxirane (intermediate 1)
The 130ml epoxy chloropropane is added in the reaction flask, after ice bath, stirring are cooled to 0~10 ℃, slowly drip 500ml sodium methyl mercaptide (dripping off in 1~2 hour).After drip finishing, remove ice bath, reaction is 3 hours under the room temperature.Separatory, get oil reservoir with anhydrous sodium sulfate drying, filtration.Filtrate steams colourless cut with 60~70 ℃ heating in water bath, decompression, collects 42-60 ℃ of cut.Get the 2-(methylthiomethyl)-oxirane (intermediate 1) 90g.
2, the preparation of 3-methylthio group-2-hydroxyl-propyl hydrazine (intermediate 2)
The 230ml hydrazine hydrate is added in the 500ml there-necked flask, be heated to 90 ℃.Splash into the 60g2-(methylthiomethyl)-oxirane (temperature control dripped off in 90~95 ℃, 1~2 hour).Dripped the Bi Jixu insulation reaction 2 hours.Be concentrated into first thickness, again-0.095 ~-distill under the 0.1MPa vacuum tightness, regather water white transparency shape liquid.Get overhead product 19g.
3, the preparation of N-amino-5-methylthiomethyl-2-oxazolidone (intermediate 3)
In there-necked flask, add 19g3-methylthio group-2-hydroxyl-propyl hydrazine, 12g methylcarbonate, 10ml sodium methoxide solution (concentration 19%), be heated to backflow.React after 2 hours, stopping to reflux steams solvent, and adding 57ml ethanol is for subsequent use.
4,5-nitryl furfural (intermediate 4) preparation
126ml ethanol, 63ml water, the 7ml vitriol oil are added in the reaction flask, add again the 31.6g5-Nitrofulral diacetate.Be heated to backflow, stopped heating after 30 minutes is cooled to room temperature for subsequent use.
5, the preparation of nifuratel crude product
To add under the N-amino-5-methylthiomethyl-2-oxazolidone lucifuge of preparation in the solution of 5-nitryl furfural of preparation, 15-30 ℃ is stirred and stops after 2 hours stirring, leaving standstill 2 hours, filters, the filter cake washing with alcohol, and drying gets 15g nifuratel crude product.
6, the purifying of nifuratel crude product
Get the 15g crude product and add the 150ml Glacial acetic acid, be heated to and boil, added again the 1g charcoal absorption 5~10 minutes; Filtered while hot, filtrate is left standstill crystallization, filters after being cooled to room temperature.Filter cake with washing with alcohol to the product redfree, use a small amount of water, washing with alcohol again.Drain rear in 50~60 ℃ of dry 7.8g nifuratels that get.(operating process lucifuge)
Embodiment 6: the amplification test that nifuratel is synthetic
Carried out scale-up according to embodiment 5 described synthetic methods, charging capacity reaches kilogram levels in the 5-Nitrofulral diacetate.Intermediate 1,2,4 reaction process are used 50L jacketed type normal-pressure reaction kettle, and intermediate 3 adopts the there-necked flask of 5L to be prepared, and its processing parameter and embodiment 5 are basically identical.Experimental result is shown in table 4 and 5.
Table 4 laboratory sample prepares the result
Figure BDA00002280352100081
The analytical results of table 5 laboratory sample
Figure BDA00002280352100082
From above-mentioned experimental result as can be known, in the building-up process of nifuratel, its processing parameter, quality product and yield are within span of control, and product has determined that through structural identification product structure is correct, and this explanation uses nifuratel synthetic method of the present invention can produce sustainedly and stably the product that meets quality standard in the laboratory.
Embodiment 6: the pilot scale amplification test that nifuratel is synthetic
On a large amount of lab scale experimental basis, we have carried out nifuratel scale-up and middle trial production, and (lot number: 070901,070902,071001,071002,071003) production technique checking, experimental result is shown in table 6 and table 7 in the workshop that meets GMP.
The raw material usage quantity of table 6 scale-up and middle trial production and product preparation amount
Figure BDA00002280352100091
The analytical results of table 7 scale-up and middle trial production
Figure BDA00002280352100092
By above-mentioned experimental result as can be known, in the building-up process of nifuratel, its quality product and yield are within span of control, show and use nifuratel synthetic method route maturation of the present invention, stable, can produce the product that meets quality standard, and good circulation ratio and reliability are arranged, be applicable to suitability for industrialized production.
The explanation of above embodiment just is used for helping to understand method of the present invention and core concept thereof.Should be pointed out that for those skilled in the art, under the prerequisite that does not break away from the principle of the invention, can also carry out some improvement and modification to the present invention, these improvement and modification also fall in the protection domain of claim of the present invention.

Claims (6)

1. the synthetic method of a nifuratel is characterized in that, may further comprise the steps:
Step 1, epoxy chloropropane is added in the reaction flask, at 0~10 ℃ of lower sodium methyl mercaptide that slowly drips, drip finish after, reaction is 3 hours under the room temperature, underpressure distillation is collected cut and is got the 2-(methylthiomethyl)-oxirane; The mol ratio of wherein said epoxy chloropropane and sodium methyl mercaptide is 1:5;
Step 2, hydrazine hydrate is added in the there-necked flask, under 90~95 ℃, splashes into the 2-(methylthiomethyl)-oxirane, dripped the Bi Jixu insulation reaction 2 hours, underpressure distillation is collected cut and is got 3-methylthio group-2-hydroxyl-propyl hydrazine; Wherein said hydrazine hydrate and 2-(methylthiomethyl)-mol ratio of oxirane is 1:1 ~ 1.1:1;
Step 3, get 3-methylthio group-2-hydroxyl-propyl hydrazine and add methylcarbonate, reacting by heating gets N-amino-5-methylthiomethyl-2-oxazolidone under the alkali existence condition; The mol ratio of wherein said 3-methylthio group-2-hydroxyl-propyl hydrazine and methylcarbonate is 1:1 ~ 1:1.2;
Step 4, get the 5-Nitrofulral diacetate and add ethanol and under the diluted acid existence condition, be hydrolyzed to get the 5-nitryl furfural; The mol ratio of wherein said ethanol and 5-Nitrofulral diacetate is 1:0.05;
Step 5, under the lucifuge condition, N-amino-5-methylthiomethyl-2-oxazolidone is mixed with the 5-nitryl furfural, 15-30 ℃ stir 2 hours after, left standstill 2 hours, filter, the filter cake washing with alcohol drying, get the nifuratel crude product, recrystallization purifying gets the nifuratel sterling; The mol ratio of wherein said N-amino-5-methylthiomethyl-2-oxazolidone and 5-nitryl furfural is 1:1 ~ 1: 1.05.
2. described synthetic method according to claim 1 is characterized in that, the described collection cut of step 1 is for collecting 42-60 ℃ of cut.
3. described synthetic method according to claim 1 is characterized in that, the described underpressure distillation of step 2 is for being concentrated into first thickness, again-0.095 ~-distill under the 0.1MPa vacuum tightness.
4. described synthetic method according to claim 1 is characterized in that, the described diluted acid of step 3 is dilute sulphuric acid.
5. described synthetic method according to claim 1 is characterized in that, the reaction conditions of the described hydrolysis of step 4 is heating reflux reaction 30 minutes.
6. described synthetic method according to claim 1 is characterized in that, the described recrystallization purifying of step 5 is specially under the lucifuge condition, get the nifuratel crude product, press g/mL, add the Glacial acetic acid of 10 times of volumes of nifuratel crude product, be heated to and boil, charcoal absorption, filtered while hot, filtrate is left standstill crystallization, filter after being cooled to room temperature, to the product redfree, water, washing with alcohol are drying to obtain after draining filter cake again with washing with alcohol.
CN201210401059.2A 2012-10-19 2012-10-19 Synthetic method of nifuratel Active CN102863434B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210401059.2A CN102863434B (en) 2012-10-19 2012-10-19 Synthetic method of nifuratel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210401059.2A CN102863434B (en) 2012-10-19 2012-10-19 Synthetic method of nifuratel

Publications (2)

Publication Number Publication Date
CN102863434A true CN102863434A (en) 2013-01-09
CN102863434B CN102863434B (en) 2014-05-28

Family

ID=47442595

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210401059.2A Active CN102863434B (en) 2012-10-19 2012-10-19 Synthetic method of nifuratel

Country Status (1)

Country Link
CN (1) CN102863434B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103232445A (en) * 2013-05-02 2013-08-07 中国医药研究开发中心有限公司 Method for preparing nifuratel
CN103396413A (en) * 2013-08-14 2013-11-20 盐城凯利药业有限公司 Preparation method of nifuratel
CN103664923A (en) * 2013-12-23 2014-03-26 湖南方盛制药股份有限公司 Preparation method for nifuratel
CN103755696A (en) * 2014-01-21 2014-04-30 北京安汀医药生物科技有限公司 Synthetic method of nifuratel
CN104402874A (en) * 2013-12-02 2015-03-11 四川摩尔生物制药有限公司 Preparation method of compound nifuratel as shown in formula E
CN105820145A (en) * 2015-01-07 2016-08-03 成都青山利康药业有限公司 Method for preparing 5-nitro-2-furaldehyde and nifuratel
CN107987069A (en) * 2017-11-28 2018-05-04 北京朗依制药有限公司 The preparation process of anti-infectives Nifuratel
CN108084174A (en) * 2017-11-28 2018-05-29 北京朗依制药有限公司 The preparation method of Nifuratel

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101037434A (en) * 2006-03-16 2007-09-19 韩志强 Production method of nifuratel

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101037434A (en) * 2006-03-16 2007-09-19 韩志强 Production method of nifuratel

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
尚红艳等: "硝呋太尔合成工艺的优化", 《河北省科学院学报》 *
李志万等: "抗感染药物硝呋太尔的合成工艺改进", 《解放军药学学报》 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103232445A (en) * 2013-05-02 2013-08-07 中国医药研究开发中心有限公司 Method for preparing nifuratel
CN103396413A (en) * 2013-08-14 2013-11-20 盐城凯利药业有限公司 Preparation method of nifuratel
CN104402874B (en) * 2013-12-02 2016-08-03 四川摩尔生物制药有限公司 A kind of preparation method of the compound nifuratel as shown in formula E
CN104402874A (en) * 2013-12-02 2015-03-11 四川摩尔生物制药有限公司 Preparation method of compound nifuratel as shown in formula E
CN103664923A (en) * 2013-12-23 2014-03-26 湖南方盛制药股份有限公司 Preparation method for nifuratel
CN103664923B (en) * 2013-12-23 2016-05-11 湖南方盛制药股份有限公司 The preparation method of Nifuratel
CN103755696A (en) * 2014-01-21 2014-04-30 北京安汀医药生物科技有限公司 Synthetic method of nifuratel
CN105820145A (en) * 2015-01-07 2016-08-03 成都青山利康药业有限公司 Method for preparing 5-nitro-2-furaldehyde and nifuratel
CN105820145B (en) * 2015-01-07 2019-01-29 成都青山利康药业有限公司 A kind of preparation method of 5- nitryl furfural and Nifuratel
CN107987069A (en) * 2017-11-28 2018-05-04 北京朗依制药有限公司 The preparation process of anti-infectives Nifuratel
CN108084174A (en) * 2017-11-28 2018-05-29 北京朗依制药有限公司 The preparation method of Nifuratel
CN108084174B (en) * 2017-11-28 2020-04-17 北京金城泰尔制药有限公司 Preparation method of nifuratel
CN107987069B (en) * 2017-11-28 2020-07-03 北京金城泰尔制药有限公司 Preparation process of anti-infective nifuratel

Also Published As

Publication number Publication date
CN102863434B (en) 2014-05-28

Similar Documents

Publication Publication Date Title
CN102863434B (en) Synthetic method of nifuratel
CN102050781B (en) Industrial preparation method of hydroxychloroquine sulfate
CN104230803B (en) Preparation method of hydroxychloroquine sulfate
CN101941969B (en) Preparation method of moxifloxacin hydrochloride
CN104974060A (en) Method for preparing sodium, 8-(2-hydroxybenzamido)octanoate
CN105061414B (en) One kettle way prepares Brexpiprazole
CN102850376B (en) One-step synthesizing method of levofloxacin and ofloxacin
CN102827042A (en) Chiral synthesis method of florfenicol
CN103613501A (en) Method for preparing tributyl citrate by taking macroporous strong-acid cation exchange resin as catalyst
CN106256824A (en) A kind of preparation method of high-purity De Lasha star meglumine salt
CN103755722B (en) The synthetic method of a kind of Levofloxacin and Ofloxacine USP 23
CN1321121C (en) Post processing method for preparing levo-ofloxacin
CN103664923B (en) The preparation method of Nifuratel
CN101962379A (en) Method for refining sulfonyl isoquinoline derivative
CN103396413A (en) Preparation method of nifuratel
CN103755696B (en) A kind of synthetic method of Nifuratel
CN101676284B (en) Preparation method of nifuratel with high purity
CN113929579A (en) Preparation method of clinafloxacin key intermediate
CN100506820C (en) (S)-nifuratel, preparation method and application thereof
CN103508974B (en) A kind of method processing adjacent sulfonamide benzoic acid methyl esters crystalline mother solution
CN103232445A (en) Method for preparing nifuratel
CN105693709A (en) Technology for producing nifuratel
CN101768167B (en) Method for synthesizing piperazine of levofloxacin
CN103910685A (en) Method used for purifying sulfadimoxine
CN103483232B (en) Refining method of valnemulin hydrochloride

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: SHANDONG LUOXIN PHARMACY GROUP CO., LTD.

Free format text: FORMER NAME: SHANDONG LUOXIN PHARMACY STOCK CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: Seven of 276017 Shandong province Linyi city Luozhuang District

Patentee after: Shandong Luo Xin Pharmaceutical Group Plc

Address before: Seven of 276017 Shandong province Linyi city Luozhuang District

Patentee before: SHANDONG LUOXIN PHARMACY STOCK Co., LTD.